EUVIMEDEUVIMED entdecken
Open Access

Secretory IgA amplification during immune checkpoint blockade enhances the control of tumor growth by enterotropic T cells

Benedetta De Ponte Conti iD, Rebecca Marino, Tanja Rezzonico-Jost iD, Mattia Forcato iD, Davide Mangani iD, Elisabetta Notario, Giorgio Gargari iD, Elena Carelli, Andrea Rinaldi iD, Andrea Raimondi iD, Simone Moro iD, Marinella Marzano iD und 15 weitere

Science Advances · 2025

DOI: 10.1126/sciadv.aeb5308 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, 2025. Verfasst von Benedetta De Ponte Conti und 26 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Research in Biomedicine, Faculty of Biomedical Sciences, Università della Svizzera Italiana, Bellinzona 6500, Switzerland. Hauptthemen laut MEDLINE: Immune Checkpoint Inhibitors, Immunoglobulin A, Secretory, Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The gut microbiota is essential for many aspects of host physiology, and secretory immunoglobulin A (sIgA) modulates its function. The microbiota community determines the efficacy of immune checkpoint blockade (ICB) in cancer immunotherapy; however, mechanisms able to improve this function are not known. Extracellular adenosine triphosphate (ATP) released by the microbiota restricts the sIgA repertoire by limiting T follicular helper (T FH ) cell activity in the Peyer’s patches via stimulation of the ionotropic P2X7 receptor. We show that sIgA amplification by oral administration of the ATP hydrolyzing enzyme apyrase corrects enteropathic features of ICB and improves therapeutic efficacy. Consistent with sIgA function in reshaping the gut ecosystem and enhancing ICB, IgA −/− mice did not show any improvement of antitumor response by apyrase administration. Mechanistically, data in mice and patients with cancer suggest that invigorated enterotropic cytotoxic T cells expressing the chemokine receptor CCR9 replenish the tumor microenvironment in a CCL25-mediated manner and control tumor growth, resulting in improved ICB efficacy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immune Checkpoint InhibitorsImmunoglobulin A, SecretoryNeoplasmsAnimalsMiceHumansTumor MicroenvironmentCell Line, TumorApyraseGastrointestinal MicrobiomeMice, KnockoutImmunotherapyReceptors, CCRMice, Inbred C57BL

Substanzen

Immune Checkpoint InhibitorsImmunoglobulin A, SecretoryApyraseCC chemokine receptor 9Receptors, CCR

Autor:innen und Institutionen

  • Institute for Research in Biomedicine, Faculty of Biomedical Sciences, Università della Svizzera Italiana, Bellinzona 6500, Switzerland.
  • Graduate School of Cellular and Molecular Sciences, University of Bern, Bern 3012, Switzerland.
  • Department of Molecular Medicine, University of Padova, Padova 35121, Italy.
  • Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies, National Research Council, Bari 70126, Italy.
  • Division of Food Microbiology and Bioprocesses, Department of Food, Environmental and Nutritional Sciences (DeFENS), University of Milan, Milan 20133, Italy.
  • Istituto Nazionale Genetica Molecolare "Romeo ed Enrica Invernizzi", Milan 20122, Italy.

ORCID-Profile: Benedetta De Ponte Conti, Tanja Rezzonico-Jost, Mattia Forcato, Davide Mangani, Giorgio Gargari, Andrea Rinaldi, Andrea Raimondi, Simone Moro, Marinella Marzano, Denise Dallavalle, Giacomo Mantegazza, Francesco Prisco, Roshan Takur, Jens Geginat, Frauke Seehusen, Samuele Notarbartolo, Graziano Pesole, Silvio Bicciato, Simone Guglielmetti, Fabio Grassi

Zitieren

APA

De Ponte Conti, B., Marino, R., Rezzonico-Jost, T., Forcato, M., Mangani, D., Notario, E., Gargari, G., Carelli, E., Rinaldi, A., Raimondi, A., Moro, S., Marzano, M., Visci, G., Perruzza, L., Raneri, M., Dallavalle, D., Mantegazza, G., Montani, L., Prisco, F., …, & Grassi, F. (2025). Secretory IgA amplification during immune checkpoint blockade enhances the control of tumor growth by enterotropic T cells. Science Advances. https://doi.org/10.1126/sciadv.aeb5308

Vancouver

De Ponte Conti B, Marino R, Rezzonico-Jost T, Forcato M, Mangani D, Notario E, et al. Secretory IgA amplification during immune checkpoint blockade enhances the control of tumor growth by enterotropic T cells. Science Advances. 2025. doi:10.1126/sciadv.aeb5308

BibTeX
@article{DePonteConti2025,
  author = {De Ponte Conti, Benedetta and Marino, Rebecca and Rezzonico-Jost, Tanja and Forcato, Mattia and Mangani, Davide and Notario, Elisabetta and Gargari, Giorgio and Carelli, Elena and Rinaldi, Andrea and Raimondi, Andrea and Moro, Simone and Marzano, Marinella and Visci, Grazia and Perruzza, Lisa and Raneri, Matteo and Dallavalle, Denise and Mantegazza, Giacomo and Montani, Ludovica and Prisco, Francesco and Takur, Roshan and Geginat, Jens and Seehusen, Frauke and Notarbartolo, Samuele and Pesole, Graziano and Bicciato, Silvio and Guglielmetti, Simone and Grassi, Fabio},
  title = {Secretory IgA amplification during immune checkpoint blockade enhances the control of tumor growth by enterotropic T cells},
  journal = {Science Advances},
  year = {2025},
  doi = {10.1126/sciadv.aeb5308}
}
Kostenlos starten →